Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLF16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DMKN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MTHFD2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBCE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPGS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISYNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR1AIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on